Thiocoraline

Drug Profile

Thiocoraline

Alternative Names: PM 93135; THIO

Latest Information Update: 21 Jul 2009

Price : $50

At a glance

  • Originator PharmaMar
  • Class Cyclic peptides; Cytostatic antibiotics
  • Mechanism of Action RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 21 Jul 2009 Preclinical development is ongoing in USA and Spain
  • 05 Aug 2005 This compound is still in active development - (BIO-2005)
  • 15 Sep 2004 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top